Healthcare
Name:
Sector:
Leukosite
Healthcare
Summary:
Leukosite acquired by Millennium Pharmaceuticals.
Stage of Initial
Investment:
Late Stage
Liquidity:
Sold to NASDAQ: MLNM
Copyright ©2007 Rho Capital Partners, Inc.
